Device Technologies Signs Exclusive Distribution Agreement with Japan Lifeline for Australia and New Zealand
Media Release ,29 October 2025
Sydney, Australia
Japan Lifeline Co. Ltd (JLL), a leading Japanese medical device company specialising in cardiology and cardiovascular surgery fields, has taken a significant step in appointing Device Technologies as their exclusive distributor in Australia and New Zealand, as they expand their presence into one of the region’s most significant healthcare markets.
The collaboration represents a major milestone in expanding access to JLL’s globally recognised technologies within the cardiology and cardiovascular space, while further strengthening Device Technologies’ extensive portfolio of innovative medical solutions.
Established in Japan, JLL possesses a strong global presence and is renowned for its innovation, quality, and expertise in delivering technologies that address complex clinical needs.
Through the agreement, Device Technologies will leverage its presence, established customer network and dedicated team of specialists across Asia Pacific, to support the adoption of JLL’s advanced technologies across hospitals and healthcare providers in Australia and New Zealand.
The collaboration reflects both organisations’ shared vision of improving patient outcomes through innovation, clinical excellence, and long-term partnerships.
Lisa Kirsch, Director of Sales – Surgical & Hospital at Device Technologies, said:
“Japan Lifeline’s portfolio is known for its precision and reliability. With decades of innovation and world-class Japanese manufacturing standards behind it, the portfolio has earned a strong reputation for consistent performance. We’re excited that through this collaboration, ANZ customers are connected to leading innovations from across the globe.”
Nobuo Takahashi, Senior Operating Officer and Head of Global Business Development Group at Japan Lifeline, said:
“We are confident that our unique products will make a significant contribution to the realisation of a healthier society in both Australia and New Zealand. Furthermore, this collaboration with Device Technologies marks a pivotal moment for our entry into the Oceania region, and we are highly enthusiastic about its potential for success.”
ENDS
For Media Enquiries Contact:
Gareth Beddoes, Seven Communications
gareth@sevencommunications.
+61 403 463 248
About Device Technologies
Device Technologies is a renowned medical technology company providing healthcare solutions, medical equipment, and technology from leading brands in Australia, New Zealand, and Asia. With over 200 trusted brands and 1000 highly skilled staff, Device Technologies is committed to enabling superior health outcomes by offering the finest medical devices and hospital supplies.
About Japan Lifeline:
Japan Lifeline Co., Ltd. (JLL) is a leading Japanese medical device company specialising in cardiology and cardiovascular fields. With state-of-the-art research, development, and manufacturing facilities in both Japan and overseas, JLL is committed to innovation, safety, and quality. Publicly listed on the Tokyo Stock Exchange, JLL continues to expand its global presence, providing healthcare professionals with trusted technologies that improve patient outcomes.
—
